Loading
The big labs that run most biomarker tests, and the reagent makers whose stains decide who gets a drug.
National reference labs (Labcorp, Quest, NeoGenomics, Mayo Clinic Laboratories, ARUP) and academic pathology departments perform IHC, FISH, and NGS at scale; Roche Tissue Diagnostics (Ventana), Agilent (Dako), and Leica Biosystems make the FDA-approved companion-diagnostic IHC assays (PD-L1 22C3/SP142/SP263, HER2 4B5) and the platforms that run them. Assay-platform pairing is why PD-L1 scores are not interchangeable across drugs.
Validated antibody clones, staining platforms, and scoring algorithms tied to a drug label; CLIA/CAP or ISO 15189 accreditation; NGS panels under FDA or LDT oversight.
Query for this technology: (TITLE:"Reference laboratories and companion-diagnostic testing" OR ABSTRACT:"Reference laboratories and companion-diagnostic testing") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Reference laboratories and companion-diagnostic testing, not a curated reading list.
Shares Leica Biosystems (Danaher), Histology automation and IHC autostainers, Diagnostics roadmap: stains → gene panels → blood tests that decide treatment, Roche / Genentech and the tag supporting.
Shares Pre-analytics: blood-collection tubes and tissue fixation, Companion diagnostics and the tag supporting.
Shares Pre-analytics: blood-collection tubes and tissue fixation and the tag supporting.
Shares Histology automation and IHC autostainers and the tag supporting.
Shares Pre-analytics: blood-collection tubes and tissue fixation and the tag supporting.
Shares Diagnostics roadmap: stains → gene panels → blood tests that decide treatment, Comprehensive genomic profiling and the tag supporting.
Shares Roche / Genentech, Comprehensive genomic profiling and the tag supporting.
Shares Comprehensive genomic profiling and the tag supporting.